Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anti-Argonaute antibodies as a potential biomarker in NMOSD.
Carta S, Le Duy D, Rogemond V, Derache N, Chaumont H, Fromont A, Cabasson S, Boudot de la Motte M, Honnorat J, Marignier R. Carta S, et al. Among authors: boudot de la motte m. J Neurol Neurosurg Psychiatry. 2023 Sep;94(9):738-741. doi: 10.1136/jnnp-2022-330707. Epub 2023 Feb 21. J Neurol Neurosurg Psychiatry. 2023. PMID: 36810322
Prospective longitudinal study on prognostic factors of visual recovery and structural change after a first episode of optic neuritis.
Deschamps R, Shor N, Vignal C, Guillaume J, Boudot de la Motte M, Salviat F, Lecler A, Marignier R, Hage R, Coulette S, Bidot S, Gueguen A, Mauget-Faysse M, Bensa C, Vasseur V, Gout O, Lamirel C. Deschamps R, et al. Among authors: boudot de la motte m. Eur J Neurol. 2022 Sep;29(9):2781-2791. doi: 10.1111/ene.15420. Epub 2022 Jun 17. Eur J Neurol. 2022. PMID: 35617154
Visual Outcomes Following Plasma Exchange for Optic Neuritis: An International Multicenter Retrospective Analysis of 395 Optic Neuritis Attacks.
Chen JJ, Flanagan EP, Pittock SJ, Stern NC, Tisavipat N, Bhatti MT, Chodnicki KD, Tajfirouz DA, Jamali S, Kunchok A, Eggenberger ER, Nome MAD, Sotirchos ES, Vasileiou ES, Henderson AD, Arnold AC, Bonelli L, Moss HE, Navarro SEV, Padungkiatsagul T, Stiebel-Kalish H, Lotan I, Wilf-Yarkoni A, Danesh-Meyer H, Ivanov S, Huda S, Forcadela M, Hodge D, Poullin P, Rode J, Papeix C, Saheb S, Boudot de la Motte M, Vignal C, Hacohen Y, Pique J, Maillart E, Deschamps R, Audoin B, Marignier R. Chen JJ, et al. Among authors: boudot de la motte m. Am J Ophthalmol. 2023 Aug;252:213-224. doi: 10.1016/j.ajo.2023.02.013. Epub 2023 Feb 21. Am J Ophthalmol. 2023. PMID: 36822570
Acute optic neuritis: What are the clues to the aetiological diagnosis in real life?
Deschamps R, Shor N, Vignal C, Guillaume J, Bensa C, Lecler A, Marignier R, Vasseur V, Papeix C, Boudot de la Motte M, Lamirel C. Deschamps R, et al. Among authors: boudot de la motte m. Mult Scler Relat Disord. 2023 Aug;76:104764. doi: 10.1016/j.msard.2023.104764. Epub 2023 May 15. Mult Scler Relat Disord. 2023. PMID: 37270881
Human pegivirus identified in severe myelitis and optic neuritis in immunocompromised patients: A pathogenic role for a forgotten virus?
Valyraki N, Maillart E, Pourcher V, Shor N, Tran S, Boudot de la Motte M, Houillier C, Domont F, Morvan E, Touat M, Del Mar Amador M, Aboab J, Mathon B, Hesters A, Vignal-Clermont C, Dehais C, Bonnin S, Lafitte F, Villain N, Varnous S, Gout O, Eloit M, Rodriguez C, Deschamps R. Valyraki N, et al. Among authors: boudot de la motte m. Rev Neurol (Paris). 2023 Apr;179(4):361-367. doi: 10.1016/j.neurol.2022.06.011. Epub 2022 Oct 24. Rev Neurol (Paris). 2023. PMID: 36302709
Natalizumab extended-interval dosing in a real-life setting.
Jeantin L, Boudot de la Motte M, Deschamps R, Gueguen A, Gout O, Lecler A, Papeix C, Bensa C. Jeantin L, et al. Among authors: boudot de la motte m. J Neurol Sci. 2023 Jul 15;450:120689. doi: 10.1016/j.jns.2023.120689. Epub 2023 May 13. J Neurol Sci. 2023. PMID: 37210938
14 results